Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floyd, Z. E.
Right arrow Articles by Stephens, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floyd, Z. E.
Right arrow Articles by Stephens, J. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:308-314, 2003
© 2003 by the American Diabetes Association, Inc.

STAT5A Promotes Adipogenesis in Nonprecursor Cells and Associates With the Glucocorticoid Receptor During Adipocyte Differentiation

Z. Elizabeth Floyd, and Jacqueline M. Stephens

From the Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana

The differentiation of adipocytes is regulated by the activity of a variety of transcription factors, including peroxidase proliferator-activated receptor (PPAR)-{gamma} and C/EBP{alpha}. Our current study demonstrates that ectopic expression of STAT5A, such as that of PPAR-{gamma} and C/EBP{alpha}, promotes adipogenesis in two nonprecursor fibroblast cell lines. Using morphologic and biochemical criteria, we have demonstrated that STAT5A and the combination of STAT5A and STAT5B are sufficient to induce the expression of early and late adipogenic markers in BALB/c and NIH-3T3 cells. Yet, the ectopic expression of STAT5B alone does not induce the expression of adipocyte genes, but enhances the induction of these genes in cells also expressing STAT5A. This finding suggests that STAT5A and STAT5B do not function identically in adipocytes. In addition, these studies demonstrate that the phosphorylation of STAT5 proteins may play a role in adipogenesis. Moreover, we have shown that STAT5A is associated with the glucocorticoid receptor during adipogenesis in a highly regulated manner.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. L. Allen, A. S. Cleary, K. J. Speaker, S. F. Lindsay, J. Uyenishi, J. M. Reed, M. C. Madden, and R. S. Mehan
Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E918 - E927.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Arai, H. Masuzaki, T. Tanaka, T. Ishii, S. Yasue, N. Kobayashi, T. Tomita, M. Noguchi, T. Kusakabe, J. Fujikura, et al.
Ceramide and Adenosine 5'-Monophosphate-Activated Protein Kinase Are Two Novel Regulators of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity in Cultured Preadipocytes
Endocrinology, November 1, 2007; 148(11): 5268 - 5277.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
U. A. White, A. A. Coulter, T. K. Miles, and J. M. Stephens
The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes
Diabetes, June 1, 2007; 56(6): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Z. E. Floyd, B. M. Segura, F. He, and J. M. Stephens
Degradation of STAT5 proteins in 3T3-L1 adipocytes is induced by TNF-{alpha} and cycloheximide in a manner independent of STAT5A activation
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E461 - E468.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. Kawai, N. Namba, S. Mushiake, Y. Etani, R. Nishimura, M. Makishima, and K. Ozono
Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPAR{gamma} pathway
J. Mol. Endocrinol., January 1, 2007; 38(1): 19 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci
Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter
J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. C. Hogan and J. M. Stephens
The Regulation of Fatty Acid Synthase by STAT5A
Diabetes, July 1, 2005; 54(7): 1968 - 1975.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gonsky, R. L. Deem, J. Bream, H. A. Young, and S. R. Targan
Enhancer Role of STAT5 in CD2 Activation of IFN-{gamma} Gene Expression
J. Immunol., November 15, 2004; 173(10): 6241 - 6247.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Shang and M. J. Waters
Constitutively Active Signal Transducer and Activator of Transcription 5 Can Replace the Requirement for Growth Hormone in Adipogenesis of 3T3-F442A Preadipocytes
Mol. Endocrinol., December 1, 2003; 17(12): 2494 - 2508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.